Madney, Y.; Aboubakr, S.; Khedr, R.; Hafez, H.; Ahmed, N.; Elsheshtawy, K.; Elanany, M.; Salahelden, A.; Shalaby, L.; Galal Behairy, O.
Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome. Antibiotics 2023, 12, 405.
https://doi.org/10.3390/antibiotics12020405
AMA Style
Madney Y, Aboubakr S, Khedr R, Hafez H, Ahmed N, Elsheshtawy K, Elanany M, Salahelden A, Shalaby L, Galal Behairy O.
Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome. Antibiotics. 2023; 12(2):405.
https://doi.org/10.3390/antibiotics12020405
Chicago/Turabian Style
Madney, Youssef, Shaimaa Aboubakr, Reham Khedr, Hanafy Hafez, Naglaa Ahmed, Khaled Elsheshtawy, Mervat Elanany, Abdelhamid Salahelden, Lobna Shalaby, and Ola Galal Behairy.
2023. "Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome" Antibiotics 12, no. 2: 405.
https://doi.org/10.3390/antibiotics12020405
APA Style
Madney, Y., Aboubakr, S., Khedr, R., Hafez, H., Ahmed, N., Elsheshtawy, K., Elanany, M., Salahelden, A., Shalaby, L., & Galal Behairy, O.
(2023). Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome. Antibiotics, 12(2), 405.
https://doi.org/10.3390/antibiotics12020405